Vanguard Group
BIVI icon

Vanguard Group’s BioVie BIVI Stock Holding History

Vanguard Group’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$248K Buy
213,531
+84,599
+66% +$136K ﹤0.01% 4080
2025
Q3 		$245K Buy
128,932
+73,695
+133% +$299K ﹤0.01% 4093
2025
Q2 		$511K Buy
55,237
+1,573
+3% +$15.5K ﹤0.01% 3914
2025
Q1 		$526K Buy
53,664
+44,636
+494% +$714K ﹤0.01% 3876
2024
Q4 		$181K Buy
9,028
+3,344
+59% +$80.6K ﹤0.01% 4115
2024
Q3 		$68.2K Hold
5,684
– – ﹤0.01% 4226
2024
Q2 		$228K Sell
5,684
-762
-12% -$36.5K ﹤0.01% 4148
2024
Q1 		$341K Buy
6,446
+2,927
+83% +$300K ﹤0.01% 4090
2023
Q4 		$443K Buy
3,519
+1,521
+76% +$457K ﹤0.01% 4077
2023
Q3 		$681K Buy
1,998
+210
+12% +$82.1K ﹤0.01% 3960
2023
Q2 		$770K Buy
1,788
+255
+17% +$172K ﹤0.01% 3978
2023
Q1 		$1.24M Buy
1,533
+1,100
+254% +$729K ﹤0.01% 3851
2022
Q4 		$337K Buy
433
+85
+24% +$46K ﹤0.01% 4198
2022
Q3 		$86K Sell
348
-1,297
-79% -$309K ﹤0.01% 4506
2022
Q2 		$238K Hold
1,645
– – ﹤0.01% 4447
2022
Q1 		$776K Hold
1,645
– – ﹤0.01% 4287
2021
Q4 		$740K Hold
1,645
– – ﹤0.01% 4346
2021
Q3 		$1.1M Buy
1,645
+667
+68% +$715K ﹤0.01% 4227
2021
Q2 		$1.66M Buy
978
+712
+268% +$1.11M ﹤0.01% 4020
2021
Q1 		$514K Buy
+266
New +$759K ﹤0.01% 4132

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group's BIVI Position: Q4 2025 in Review

Vanguard Group increased its BioVie (BIVI) stake by 66% in Q4 2025, buying an estimated $136K and bringing the position to 213,531 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #4080.

Vanguard Group first reported a position in BIVI in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.66M in Q2 2021. 35 funds tracked by Wall St. Rank hold BIVI as of Q4 2025.

  • Vanguard Group held 213,531 shares of BioVie worth $248K as of Q4 2025.
  • Vanguard Group bought 84,599 BioVie shares in Q4 2025, an estimated $136K.
  • BioVie made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4080 holding.
  • Vanguard Group first reported a position in BioVie in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's BioVie position peaked at $1.66M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held BioVie as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.